Table 1.
Patient Characteristics among eligible patients on AHOD0431
| N=278 | |
|---|---|
| Gender | |
|
| |
| male | 123 (44.2%) |
|
| |
| female | 155 (55.8%) |
|
| |
| Race | |
|
| |
| white | 217 (78.1%) |
|
| |
| black | 27 (9.7%) |
|
| |
| other | 8 (2.9%) |
|
| |
| missing | 26 (9.4%) |
|
| |
| Ethnicity | |
|
| |
| non-Hispanic | 222 (79.9%) |
|
| |
| Hispanic | 40 (14.4%) |
|
| |
| missing | 16 (5.8%) |
|
| |
| Stage | |
|
| |
| I | 67 (24.1%) |
|
| |
| II | 211 (75.9%) |
|
| |
| Age at enrollment | |
|
| |
| Median/range (years) | 15.3 (3.0–21.9) |
|
| |
| Pathology by central review | |
|
| |
| NS | 179 (64.4%) |
|
| |
| MC | 42 (15.1%) |
|
| |
| other/missing | 57 (20.5%) |
|
| |
| ESR | |
|
| |
| <=20 mm/hr | 143 (51.4%) |
|
| |
| >20 mm/hr | 134 (48.2%) |
|
| |
| missing | 1 (0.4%) |
|
| |
| CRP | |
|
| |
| <=2x Upper Limit | 173 (62.2%) |
|
| |
| >2x Upper Limit | 80 (28.8%) |
|
| |
| missing | 25 (9.0%) |
|
| |
| Number of Disease Sites | |
|
| |
| 1–2 | 183 (65.8%) |
|
| |
| 3+ | 92 (33.1%) |
|
| |
| missing | 3 (1.1%) |
Abbreviations: NS, Nodular Sclerosis; MC, Mixed Cellularity; ESR, Erythrocyte Sedimentation Rate; CRP, C-Reactive Protein; mm/hr, millimeter/hour; CR, Complete Remission; PR, Partial Remission; SD, Stable Disease